454 Life Sciences and Roche NimbleGen Announce Collaboration with Eli Lilly and SeqWright
Sequencing Genomic Regions Associated with Psychiatric Disease
03-Aug-2009 -
454 Life Sciences, a Roche company, and Roche NimbleGen, both units of Roche Applied Science, have announced a collaboration with Eli Lilly and Company and SeqWright. The goal of this collaboration is to use genomic technologies to identify genetic variants possibly associated with various ...
biomarkers
Eli Lilly
human genome
+3